Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTX-010 in Extensive-Stage Small Cell Lung Cancer
NCT01017601Phase 2Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2010
- Primary completion
- Jan 2013
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of Seneca Valley Virus in small cell lung cancer (SCLC), sponsored by Cancer and Leukemia Group B. Started Jan 2010; status: terminated.
02
Drugs
Seneca Valley Virus
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01017601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017601.